Cargando…
Effects of C1-INH Treatment on Neurobehavioral Sequelae and Late Seizures After Traumatic Brain Injury in a Mouse Model of Controlled Cortical Impact
C1 human-derived C1 esterase inhibitor (C1-INH) is a U.S. Food and Drig Administration–approved drug with anti-inflammatory actions. In the present study, we investigated the therapeutic effects of C1-INH on acute and chronic neurobehavioral outcomes and on seizures in the chronic stage in a mouse t...
Autores principales: | Chen, Min, Tieng, Quang M., Du, Jiaxin, Edwards, Stephen R., Maskey, Dhiraj, Peshtenski, Emil, Reutens, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024590/ https://www.ncbi.nlm.nih.gov/pubmed/36941878 http://dx.doi.org/10.1089/neur.2022.0011 |
Ejemplares similares
-
Complement Component 5 (C5) Deficiency Improves Cognitive Outcome After Traumatic Brain Injury and Enhances Treatment Effects of Complement Inhibitors C1-Inh and CR2-Crry in a Mouse Model
por: Chen, Min, et al.
Publicado: (2023) -
Small changes in synaptic gain lead to seizure-like activity in neuronal network at criticality
por: Du, Jiaxin, et al.
Publicado: (2019) -
Measuring Neurobehavioral Functioning in People With Traumatic Brain Injury: Rasch Analysis of Neurobehavioral Functioning Inventory
por: Czuba, Karol J., et al.
Publicado: (2016) -
Urinary bladder cancer as a late sequela of traumatic spinal cord injury
por: Böthig, Ralf, et al.
Publicado: (2021) -
Animal Models of Virus-Induced Neurobehavioral Sequelae: Recent Advances, Methodological Issues, and Future Prospects
por: Bortolato, Marco, et al.
Publicado: (2010)